- $460.50m
- $288.19m
- $255.45m
- 61
- 97
- 58
- 83
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Interest Income | |||||
Interest Expense | |||||
Net Interest Income | 176 | 181 | 195 | 238 | 221 |
Loan Loss Provision | |||||
Net Interest Income After Loan Loss Provision | 146 | 135 | 219 | 237 | 217 |
Non Interest Income | |||||
Non Interest Expense | |||||
Net Income Before Taxes | 47.3 | 59.5 | 135 | 141 | 115 |
Provision for Income Taxes | |||||
Net Income After Taxes | 32.8 | 42.2 | 98.7 | 101 | 80 |
Net Income Before Extraordinary Items | |||||
Net Income | 32.8 | 42.2 | 98.7 | 101 | 80 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 32.6 | 41.7 | 98 | 101 | 79.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.06 | 1.38 | 3.22 | 3.32 | 2.62 |
Dividends per Share |